home / stock / bgne / bgne short
Short Information | BeiGene Ltd. (NASDAQ:BGNE)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 650,320 |
Total Actual Volume | 3,243,994 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 32,516 |
Average Short Percentage | 20.75% |
Is there a BGNE Short Squeeze or Breakout about to happen?
See the BGNE Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-16-2024 | $137.28 | $134.05 | $137.705 | $133.71 | 308,982 | 56,826 | 18.39% |
04-15-2024 | $140.68 | $138.4 | $142.63 | $137.375 | 228,159 | 69,932 | 30.65% |
04-12-2024 | $145 | $141.3 | $146.805 | $140.08 | 139,454 | 28,788 | 20.64% |
04-11-2024 | $147.62 | $146.13 | $148.93 | $145.34 | 243,171 | 42,213 | 17.36% |
04-10-2024 | $150.34 | $149.76 | $150.975 | $147.975 | 272,924 | 48,469 | 17.76% |
04-09-2024 | $153.7 | $154.02 | $155.37 | $150.84 | 115,201 | 32,522 | 28.23% |
04-08-2024 | $148.84 | $149.75 | $151.52 | $148.5 | 109,180 | 17,932 | 16.42% |
04-05-2024 | $149.57 | $150.03 | $151.445 | $148 | 90,661 | 16,002 | 17.65% |
04-04-2024 | $153.26 | $149.57 | $153.28 | $149.3 | 81,654 | 15,280 | 18.71% |
04-03-2024 | $153.53 | $151.95 | $154.1224 | $150.79 | 56,991 | 13,723 | 24.08% |
04-02-2024 | $155.51 | $153.25 | $157.32 | $152.695 | 84,095 | 21,152 | 25.15% |
04-01-2024 | $156.87 | $159.23 | $159.34 | $152.77 | 126,964 | 36,081 | 28.42% |
03-28-2024 | $157 | $156.39 | $157.38 | $155.09 | 104,129 | 21,239 | 20.4% |
03-27-2024 | $153.05 | $155.08 | $155.915 | $153.05 | 76,134 | 17,029 | 22.37% |
03-26-2024 | $155.96 | $153.81 | $155.99 | $151.49 | 104,417 | 24,697 | 23.65% |
03-25-2024 | $153.14 | $153.92 | $155.63 | $151.945 | 122,678 | 19,599 | 15.98% |
03-22-2024 | $156.48 | $152.02 | $158.1 | $151.85 | 445,487 | 79,088 | 17.75% |
03-21-2024 | $167.1 | $163.7 | $167.835 | $162.5 | 192,989 | 32,903 | 17.05% |
03-20-2024 | $169.44 | $169.62 | $170.3599 | $166.66 | 195,654 | 27,128 | 13.87% |
03-19-2024 | $168.31 | $168.1 | $171.25 | $165.83 | 145,070 | 29,717 | 20.48% |
News, Short Squeeze, Breakout and More Instantly...
BeiGene Ltd. Company Name:
BGNE Stock Symbol:
NASDAQ Market:
2024-04-08 11:30:04 ET Bank of America Securities analyst issues NEUTRAL recommendation for BGNE on April 8, 2024 09:28AM ET. The previous analyst recommendation was Neutral. BGNE was trading at $149.29 at issue of the analyst recommendation. The overall analyst consensu...
U.S. stock futures were higher this morning, with the Dow futures gaining by around 0.1% on Friday. Shares of Lululemon Athletica Inc. (NASDAQ: L...
On Thursday, the FDA approved BeiGene Ltd’s (NASDAQ:BGNE) approved Tevimbra (tislelizumab-jsgr) as monotherapy for adult patients w...